Alector (ALEC) News Today $1.71 +0.03 (+1.79%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Alector, Inc. (NASDAQ:ALEC) Receives Consensus Recommendation of "Hold" from BrokeragesJanuary 20 at 2:00 AM | americanbankingnews.comAlector, Inc. (NASDAQ:ALEC) Sees Large Drop in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 5,170,000 shares, a decline of 8.5% from the December 15th total of 5,650,000 shares. Approximately 6.8% of the company's stock are short sold. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is currently 4.1 days.January 18 at 5:20 AM | marketbeat.comBTIG Remains a Buy on Alector (ALEC)January 16, 2025 | markets.businessinsider.comWhy AbbVie Stock is on SaleJanuary 15, 2025 | baystreet.caAlector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from AnalystsShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have received an average recommendation of "Hold" from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and three haJanuary 15, 2025 | marketbeat.comAlector (ALEC) Receives a Sell from Bank of America SecuritiesJanuary 14, 2025 | markets.businessinsider.comSell Rating on Alector Due to Delays in Key Data Releases and Low Market CapJanuary 14, 2025 | markets.businessinsider.comAlector, Inc. Advances Neurodegeneration Pipeline with Key Clinical Trials and Strong Financial Position for 2025January 13, 2025 | quiverquant.comAlector Reports on Recent Progress and Outlines Strategic Priorities for 2025January 13, 2025 | globenewswire.comAlector, Inc. (NASDAQ:ALEC) Stake Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. grew its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 64.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,728,823 shares of the company's stock afterJanuary 12, 2025 | marketbeat.comAbbVie terminates Alector collaboration agreementJanuary 10, 2025 | msn.comAlector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Hold" from BrokeragesShares of Alector, Inc. (NASDAQ:ALEC - Get Free Report) have been assigned an average rating of "Hold" from the seven brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three haveDecember 21, 2024 | marketbeat.comAlector downgraded to Neutral from Outperform at MizuhoDecember 17, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Stock Rating Lowered by MizuhoMizuho cut shares of Alector from an "outperform" rating to a "neutral" rating and dropped their target price for the stock from $9.00 to $2.50 in a research report on Tuesday.December 17, 2024 | marketbeat.comStifel Downgrades Alector (ALEC)December 17, 2024 | msn.comMizuho Securities downgrades Alector (ALEC) to a HoldDecember 17, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Rating Lowered to "Hold" at Stifel NicolausStifel Nicolaus cut Alector from a "buy" rating to a "hold" rating and set a $4.00 target price on the stock. in a report on Monday.December 16, 2024 | marketbeat.comVerition Fund Management LLC Sells 473,794 Shares of Alector, Inc. (NASDAQ:ALEC)Verition Fund Management LLC lowered its stake in Alector, Inc. (NASDAQ:ALEC - Free Report) by 88.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 64,369 shares of the company's stock after selling 473,794 shares during the quarter. Verition Fund ManagemenDecember 15, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) Sees Significant Increase in Short InterestAlector, Inc. (NASDAQ:ALEC - Get Free Report) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 5,390,000 shares, an increase of 34.1% from the November 15th total of 4,020,000 shares. Based on an average daily volume of 1,010,000 shares, the short-interest ratio is presently 5.3 days. Approximately 7.1% of the company's stock are sold short.December 13, 2024 | marketbeat.comPoint72 Asset Management L.P. Decreases Stake in Alector, Inc. (NASDAQ:ALEC)Point72 Asset Management L.P. lowered its stake in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 86.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,538 shares of the company's stock afteDecember 13, 2024 | marketbeat.comBank of America Downgrades Alector (NASDAQ:ALEC) to UnderperformBank of America downgraded Alector from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $9.00 to $1.00 in a research note on Wednesday.December 4, 2024 | marketbeat.comAlector, Inc. (NASDAQ:ALEC) CFO Sells $41,552.28 in StockDecember 4, 2024 | insidertrades.comBraidwell LP Cuts Stock Position in Alector, Inc. (NASDAQ:ALEC)Braidwell LP decreased its stake in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 9.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,158,245 shares of the company's stock after selling 222,459 shares duringNovember 29, 2024 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for Alector (NASDAQ:ALEC) Stock PriceHC Wainwright cut their target price on shares of Alector from $35.00 to $7.00 and set a "buy" rating for the company in a research report on Friday.November 29, 2024 | marketbeat.comWhat is HC Wainwright's Forecast for Alector Q1 Earnings?Alector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Alector in a research note issued to investors on Tuesday, November 26th. HC Wainwright analyst A. Fein anticipates that the company will pNovember 28, 2024 | marketbeat.comAlector: Bleak Prospects After Alzheimer's FailureNovember 28, 2024 | seekingalpha.comMorgan Stanley Downgrades Alector (ALEC)November 27, 2024 | msn.comAlector’s Strategic Pipeline and Promising PGRN Program Justify Buy Rating Despite AL002 SetbackNovember 27, 2024 | markets.businessinsider.comAlector turns to layoffs as Alzheimer’s drug failsNovember 27, 2024 | finance.yahoo.comBuy Rating Maintained for Alector Despite AL002 Setback, Focus on Promising AL001 and Strong FinancialsNovember 26, 2024 | markets.businessinsider.comAlector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business UpdateNovember 26, 2024 | finance.yahoo.comAlector stock drops after Alzheimer’s drug fails in Phase II trialNovember 26, 2024 | finance.yahoo.comAlector (NASDAQ:ALEC) Rating Lowered to "Underweight" at Morgan StanleyMorgan Stanley cut shares of Alector from an "equal weight" rating to an "underweight" rating and lowered their target price for the stock from $10.00 to $3.00 in a research note on Tuesday.November 26, 2024 | marketbeat.comAlector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business UpdateNovember 25, 2024 | globenewswire.comAlector’s Strategic Advances in Immuno-NeurologyNovember 22, 2024 | markets.businessinsider.comAlector Secures Funding to Advance Clinical TrialsNovember 15, 2024 | markets.businessinsider.comAlector Secures Flexible Credit Facility for Up to $50 Million From Hercules CapitalNovember 14, 2024 | globenewswire.comAlector, Inc. (NASDAQ:ALEC) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. cut its holdings in shares of Alector, Inc. (NASDAQ:ALEC - Free Report) by 69.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,835 shares of the company's stock after selling 181,November 14, 2024 | marketbeat.comFY2024 Earnings Forecast for Alector Issued By HC WainwrightAlector, Inc. (NASDAQ:ALEC - Free Report) - Equities research analysts at HC Wainwright lifted their FY2024 earnings per share (EPS) estimates for Alector in a report released on Thursday, November 7th. HC Wainwright analyst A. Fein now forecasts that the company will earn ($1.79) per share for tNovember 11, 2024 | marketbeat.comWilliam Blair Has Strong Outlook for Alector FY2024 EarningsAlector, Inc. (NASDAQ:ALEC - Free Report) - Investment analysts at William Blair increased their FY2024 earnings estimates for shares of Alector in a research note issued to investors on Wednesday, November 6th. William Blair analyst M. Minter now anticipates that the company will post earnings pNovember 11, 2024 | marketbeat.comAlector (NASDAQ:ALEC) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPSAlector (NASDAQ:ALEC - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.43) earnings per share for the quarter, topping analysts' consensus estimates of ($0.53) by $0.10. The firm had revenue of $15.34 million during the quarter, compared to analysts' expectations of $16.33 million. Alector had a negative net margin of 290.66% and a negative return on equity of 102.63%.November 9, 2024 | marketbeat.comStifel Nicolaus Sticks to Its Buy Rating for Alector (ALEC)November 9, 2024 | markets.businessinsider.comPromising Developments in Alector’s Alzheimer’s Treatments Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector’s Promising Phase 2 Study and Strong Financial Outlook Justify Buy RatingNovember 7, 2024 | markets.businessinsider.comAlector (NASDAQ:ALEC) Receives Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $35.00 price target on shares of Alector in a research note on Thursday.November 7, 2024 | marketbeat.comAlector Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 6, 2024 | globenewswire.comAlector (NASDAQ:ALEC) Stock Price Up 7% - Still a Buy?Alector (NASDAQ:ALEC) Trading 7% Higher - Should You Buy?November 4, 2024 | marketbeat.comIs Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?October 30, 2024 | finance.yahoo.comCautious Optimism for Alector’s AL002 Amid Promising Alzheimer’s Data and Investor CautionOctober 25, 2024 | markets.businessinsider.comAlector (ALEC) Receives a Buy from BarclaysOctober 19, 2024 | markets.businessinsider.com Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address ALEC Media Mentions By Week ALEC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALEC News Sentiment▼0.580.48▲Average Medical News Sentiment ALEC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALEC Articles This Week▼72▲ALEC Articles Average Week Get Alector News Delivered to You Automatically Sign up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 89bio News Evolus News Bicara Therapeutics News Immatics News Immunome News Ginkgo Bioworks News LENZ Therapeutics News Arbutus Biopharma News Tectonic Therapeutic News Cullinan Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALEC) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALEC Stock Alerts